Lentiviral vectors (LVV) represent an important tool for vaccine
development and other therapeutic modalities. However, inefficiencies in
LVV manufacturing processes, such as the inability to achieve high cell
densities with HEK293T cell lines in a fed batch process, have resulted
in poor upstream yields. Optimisation of cell culture conditions is
needed to improve upstream yields, which can be expedited by
high-throughput screening (HTP). In this work, we describe the use of
the 24 deep square well (24-DSW) microwell platform to develop a
scale-down mimic of GSK’s established stable suspension LVV production
process model at 2 L bioreactor scale. We found that matched mixing time
was an effective basis for scale-translation between the stirred tank
reactor (STR) and microwells. The growth kinetics and LVV productivity
profile in the microwell were reproducible and comparable to the 2 L
bioreactor process model. In both vessels, a 6-fold increase in cell
density was achieved at the harvest time point and high cell viability
(i.e. > 90 %) was also maintained throughout the entirety
of the cultures. The 24-DSW model, therefore, is an effective scale-down
model for larger-scale stirred-tank bioreactor culture and provides an
important tool for rapid, high-throughput optimization of the LVV
production process.